GPER activation upregulates interleukin-1 receptor-1 (IL1R1) expression on breast cancer cells and interleukin (IL)-1β expression on cancer associated fibroblasts in a signalling loop to encourage invasive features of breast cancer [13]. The gene discussed is IL1B; the disease is breast carcinoma.